{
    "accessibility": "Open access",
    "additionDate": "2023-12-01T13:04:26.255109Z",
    "biotoolsCURIE": "biotools:resistor",
    "biotoolsID": "resistor",
    "confidence_flag": "high",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "brd+sp22@cs.duke.edu",
            "name": "Bruce R. Donald",
            "typeEntity": "Person"
        },
        {
            "email": "osprey@cs.duke.edu",
            "name": "Nathan Guerin",
            "typeEntity": "Person"
        }
    ],
    "description": "Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTOR.",
    "documentation": [
        {
            "type": [
                "Installation instructions"
            ],
            "url": "https://www.cs.duke.edu/donaldlab/software/osprey/docs/documentation/"
        }
    ],
    "editPermission": {
        "type": "public"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Protein design",
                    "uri": "http://edamontology.org/operation_4008"
                },
                {
                    "term": "Protein modelling",
                    "uri": "http://edamontology.org/operation_0477"
                }
            ]
        }
    ],
    "homepage": "https://github.com/donaldlab/OSPREY3/releases/3.3-resistor",
    "language": [
        "C",
        "C++",
        "Java",
        "Python"
    ],
    "lastUpdate": "2023-12-01T13:04:26.257812Z",
    "license": "GPL-2.0",
    "name": "RESISTOR",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1016/J.XPRO.2023.102170",
            "metadata": {
                "abstract": "Prospective predictions of drug-resistant protein mutants could improve the design of therapeutics less prone to resistance. Here, we describe RESISTOR, an algorithm that uses structure- and sequence-based criteria to predict resistance mutations. We demonstrate the process of using RESISTOR to predict ERK2 mutants likely to arise in melanoma ablating the efficacy of the ERK1/2 inhibitor SCH779284. RESISTOR is included in the free and open-source computational protein design software OSPREY. For complete details on the use and execution of this protocol, please refer to Guerin et al..1",
                "authors": [
                    {
                        "name": "Donald B.R."
                    },
                    {
                        "name": "Guerin N."
                    },
                    {
                        "name": "Kaserer T."
                    }
                ],
                "date": "2023-06-16T00:00:00Z",
                "journal": "STAR Protocols",
                "title": "Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTOR"
            },
            "pmcid": "PMC10173857",
            "pmid": "37115667",
            "type": [
                "Primary"
            ]
        }
    ],
    "toolType": [
        "Desktop application"
    ],
    "topic": [
        {
            "term": "Biochemistry",
            "uri": "http://edamontology.org/topic_3292"
        },
        {
            "term": "Bioengineering",
            "uri": "http://edamontology.org/topic_3398"
        },
        {
            "term": "Genetic variation",
            "uri": "http://edamontology.org/topic_0199"
        },
        {
            "term": "NMR",
            "uri": "http://edamontology.org/topic_0593"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        }
    ]
}
